Risk of Haemophilus influenzae type b meningitis in Polish children varies directly with number of siblings: Possible implications for vaccination strategies

被引:0
作者
Andrzej Zielinski
Christy B. Kwon
Joanna Tomaszunas-Blaszczyk
Wieslaw Magdzik
John V. Bennett
机构
[1] National Institute of Hygiene,National Research Center of Public Health
[2] Emory University,Department of Epidemiology, Rollins School of Public Health
来源
European Journal of Epidemiology | 2003年 / 18卷
关键词
Childcare; Epidemiology; type b (Hib); Matched case–control study; Meningitis; Poland; Siblings;
D O I
暂无
中图分类号
学科分类号
摘要
Background: In the absence of an effective vaccine, Haemophilus influenzae type b (Hib) meningitis has frequently been found to be the most common bacterial meningitis among children less than or equal to 5 years of age. This study was conducted prior to the introduction of Hib vaccine in Poland, and is the first case–control study of Hib meningitis in this country. Methods: A 1:3 matched case–control study was nested within a population-based surveillance study of Hib meningitis in children less than or equal to 5 years old in Poland. Controls were matched on the case's age at onset of disease and immunization center. Results: Having one or more siblings is a highly significant risk factor for Hib meningitis and, under the rare disease assumption, risk increases linearly with the increase in the number of siblings. The size of the living area of the home was not itself a significant risk factor for disease. Breast-feeding was not protective in contrast to previous studies. Childcare outside of the home was a significant risk factor for Hib meningitis especially among children greater than 16 months of age, whereas the effect of sibling number on Hib meningitis was much greater among the younger children. Conclusion: Risk of Hib meningitis approximately doubles for every unit increase in the number of siblings. Routine vaccination of Polish infants who have two or more siblings could potentially prevent half of the Hib meningitis cases.
引用
收藏
页码:917 / 922
页数:5
相关论文
共 79 条
[1]  
Black SB(1996)Progress toward elimination of MMWR 45 901-906
[2]  
Shinefield HR(1988) type b disease among infants and children - United States, 1987-1995 J Pediatr 7 149-156
[3]  
Hiatt RA(1988)The Kaiser Permanente Pediatric Vaccine Study. Efficacy of J Pediatr 7 156-159
[4]  
Fireman BH.(1988) type b capsular polysaccharide vaccine JAMA 260 1419-1422
[5]  
Musher DM(1996)Vaccination of 18-month-old children with conjugated polyribosyl ribitol phosphate stimulate production of functional antibody to Int J Epidemiol 25 1280-1285
[6]  
Watson DA(1997) type b Eur J Pediatr 156 282-287
[7]  
Lepow ML(1985)The protective efficacy of J Pediatr 106 190-195
[8]  
McVerry P(1985) b polysaccharide vaccine JAMA 253 1749-1754
[9]  
Hamill R(1986)The Swiss J Pediatr 108 887-896
[10]  
Baughn RE.(1987) study Group. Risk factors for invasive Pediatr Infect Dis J 6 779-782